Organoid/3D Culture Thawing and Re-Embedding
Materials Required
Principle
Organoid/3D culture thawing and re-embedding restores cryopreserved organoid fragments or organoid-forming epithelial cells into a three-dimensional extracellular matrix environment that supports epithelial survival, self-organization, proliferation, and lineage differentiation; classic intestinal organoid studies showed that Lgr5-positive intestinal stem cells or crypt-derived cells embedded in Matrigel can form crypt-villus-like epithelial structures, and later human intestinal protocols used similar matrix-embedded culture logic for establishment, passaging, cryopreservation, and thawing[1][2][3]. The readout of successful thawing and re-embedding is recovery of viable three-dimensional organoid growth after plating, assessed by bright-field morphology, expansion, budding or cystic architecture depending on tissue type, and downstream assays such as immunofluorescence, RNA analysis, or drug-response testing when these are part of the organoid model workflow[1][3][4].
MCE has not independently verified the accuracy of these methods. They are for reference only.
Experimental Materials
• Use Matrigel or basement-membrane extract as the embedding matrix when following the cited intestinal and human epithelial organoid protocols, because Matrigel is a biologically active basement-membrane matrix and has been used to support three-dimensional organoid growth[1][2][3][5].
• Use cold basal medium or buffer for washing and handling organoid fragments after thawing, because published organoid protocols process organoids under cold conditions during recovery and re-embedding steps to limit premature matrix handling problems[1][4].
• Optional post-thaw validation may use immunofluorescence markers appropriate to the organoid tissue type, as reported in organoid culture workflows[1][4].
• Required equipment includes a liquid-nitrogen or ultra-low-temperature cryostorage system for stored organoids, a 37°C water bath for rapid vial thawing, a biosafety cabinet for aseptic handling, a refrigerated centrifuge for washing recovered organoids, low-attachment or tissue-culture plates depending on the published model, standard micropipettes, and an incubator set for mammalian organoid culture conditions[1][4].
Experimental Procedure
• Pre-label culture plates and prepare an embedding plan before removing cryovials from storage, because thawed organoid material should be diluted, washed, and re-embedded promptly rather than left in cryoprotectant-containing suspension[1][4].
• Remove the cryovial from cryostorage and thaw it rapidly in a 37°C water bath until the frozen contents are just liquefied, then transfer the contents aseptically into pre-prepared medium for dilution and recovery[1][4].
• Wash the thawed organoid suspension by centrifugation using the conditions specified in the selected tissue-specific protocol; where studies differ, use the published centrifugation condition for the same organoid system rather than transferring a parameter from another tissue model[1][4].
• Remove the supernatant after centrifugation and resuspend the organoid pellet or fragments gently in cold extracellular matrix; avoid unsupported single-cell dissociation during thaw recovery unless the cited protocol for that organoid system specifically uses single-cell recovery[1][3][4].
• Dispense the organoid-matrix suspension as domes or matrix-embedded droplets according to the published plate format for the model, allow the matrix to gel under incubator conditions, and then overlay with complete organoid growth medium[1][3][4][5].
• Maintain cultures in the tissue-specific organoid medium and inspect recovery by bright-field microscopy over the first several days; successful recovery is indicated by organoid survival and expansion rather than immediate endpoint readout on the day of thawing[1][3][4].
• For proteomic or matrix-sensitive downstream assays after re-embedding, remove or dissolve Matrigel using a literature-supported method before sample preparation; one comparative study found dispase gave the highest peptide yield and lowest apparent Matrigel contamination among cell recovery solution, dispase, and PBS-EDTA buffer for organoid proteomics[6].
• Record post-thaw recovery using bright-field images, organoid number or outgrowth efficiency when reported by the model-specific protocol, and morphology appropriate to the organoid type; downstream validation may include immunofluorescence, transcript analysis, or functional assays depending on the experimental purpose[1][3][4].
• Use matched biological replicates from independent organoid lines or donors when the study question concerns donor variability, and use technical replicate wells when comparing post-thaw plating conditions, because patient-derived and adult-stem-cell organoid workflows are commonly interpreted at both culture-line and well levels[1][4].
• Include a positive control consisting of a previously validated organoid line thawed and re-embedded under the same conditions, and include a negative process control consisting of matrix plus medium without organoids to monitor contamination and background imaging[1][4].
Troubleshooting
Problem: Few or no organoids recover after thawing.
• Possible cause: The organoid model may require tissue-specific niche factors and matrix-embedded culture conditions rather than a generic 3D culture medium.• Literature-supported solution: Use the organoid growth medium and extracellular matrix conditions reported for the same tissue or disease model, and do not substitute unsupported medium formulations[1][3][4].
Problem: Matrix-associated material interferes with downstream proteomic analysis.
• Possible cause: Residual Matrigel proteins can contaminate organoid proteomic samples.• Literature-supported solution: For proteomic workflows, use a validated Matrigel dissolution strategy; Wang et al. reported that dispase performed best among the compared methods for peptide yield and reduced Matrigel interference[6].
Problem: Organoids grow but morphology or expansion is inconsistent across experiments.
• Possible cause: Organoid systems are sensitive to tissue source, culture medium, and extracellular matrix context.• Literature-supported solution: Compare only organoids maintained under the same tissue-specific protocol and document donor line, passage, matrix, and medium conditions for each thaw and re-embedding experiment[1][3][4][7].
References:
- [1]. Pleguezuelos-Manzano C, et al. Establishment and Culture of Human Intestinal Organoids Derived from Adult Stem Cells. Curr Protoc Immunol. 2020;130(1):e106. [Content Brief]
- [2]. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459(7244):262-265. [Content Brief]
- [3]. Sato T, Stange DE, Ferrante M, Vries RG, van Es JH, van den Brink S, et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology. 2011;141(5):1762-1772. [Content Brief]
- [4]. Driehuis E, et al. Establishment of patient-derived cancer organoids for drug-screening applications. Nat Protoc. 2020;15(10):3380-3409. [Content Brief]
- [5]. Kleinman HK, et al. Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol. 2005;15(5):378-386. [Content Brief]
- [6]. Wang M, Yu H, Zhang T, Cao L, Du Y, Xie Y, et al. In-Depth Comparison of Matrigel Dissolving Methods on Proteomic Profiling of Organoids. Mol Cell Proteomics. 2022;21(1):100181. [Content Brief]
- [7]. Zhao Z, Chen X, Dowbaj AM, Sljukic A, Bratlie K, Lin L, et al. Organoids. Nat Rev Methods Primers. 2022;2:94. [Content Brief]